Repetitive transcranial magnetic stimulation (rTMS), an established treatment for treatment-
resistant depression, may hold promise as a personalized medicine approach for the
treatment of major depressive disorder (MDD). Clinical research has begun to identify
patient-specific factors that could be used to guide rTMS treatment decisions or
individualized treatment approaches. This literature review describes a range of patient
factors which have been evaluated as potential biomarkers of rTMS treatment response …